Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.25 USD | -3.94% | -16.63% | -45.59% |
23/05 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
22/05 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.59% | 85Cr | |
+9.85% | 12TCr | |
+10.64% | 11TCr | |
-10.92% | 2.34TCr | |
-1.69% | 2.21TCr | |
-10.23% | 1.83TCr | |
-41.92% | 1.66TCr | |
-15.58% | 1.6TCr | |
+7.01% | 1.4TCr | |
+17.73% | 1.17TCr |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- Insider Buy: Scholar Rock Holding